SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-140987
Filing Date
2020-12-31
Accepted
2020-12-31 16:25:18
Documents
13
Period of Report
2020-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2039613d1_8k.htm   iXBRL 8-K 25105
2 EXHIBIT 1.1 tm2039613d1_ex1-1.htm EX-1.1 37831
  Complete submission text file 0001104659-20-140987.txt   242312

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbio-20201231.xsd EX-101.SCH 3193
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20201231_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20201231_pre.xml EX-101.PRE 22715
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2039613d1_8k_htm.xml XML 3600
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 201429094
SIC: 2834 Pharmaceutical Preparations